Zaltoprofen
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384520This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H14O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H8635NG3PY, chemically known as 10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic acid but generally known as zaltoprofen, which bears US NIH Compound Identifier 5720. European Medicines Agency schedules Zaltoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00135MIG. The term ZALTOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). ZALTOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zaltoprofen under HS 29349990 and SITC 51579. As of Q4 2014, ZALTOPROFEN remains the US FDA Preferred Term for this commodity. Zaltoprofen bears US NLM identifiers UMLS ID C2930434 and NCI Concept Code C66681. SMILES: S1C2C(CC(=O)C3C1CCCC3)CC(C(C)C(=O)O)CC2.
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.